Small caps

After the minor shock of Omicron, the COVID-19 pandemic looks to be nearing its end for most locations. A new world order post covid is characterised by geo-political tensions, heightened inflation and rising interest rates. Asset manager, Datt Capital, is of the view that investing will remain challenging in an unstable post-covid environment. Emanuel Datt,…

First, it was GameStop and the era of the ‘meme’ stocks. Then it was the Archegos hedge fund making massive bets on well-known technology companies. More recently, it was a massive spike in the price of Nickel. What all these events have in common was that they all involved a ‘short squeeze’. Short squeezes have…

Blood diagnostic company Haemokinesis Limited is ASX-bound, with its $17 million share issue, at 20 cents a share, closing this Wednesday, with Haemokinesis expected to commence trading on the exchange on Friday, 8 April. When it hits the screens Haemokinesis will have a market capitalisation of $77 million. Haemokinesis – which means “moving blood with…

Hong Kong stocks are on a tear, rising some 7 per cent in the past week at the time of writing, boosted by the tech sector. It’s all to do with the US regulators wanting to delist Chinese stocks. China’s Securities Regulatory Commission is considering allowing US officials to inspect documents on firms that don’t…

Australia’s very own home-grown semiconductor company, BrainChip Holdings (ASX:BRN), has more than doubled in price in 2022 so far, as investors lap-up news including that of a new US patent, the eighth patent the company has secured since 2008.  BrainChip bills itself as the world’s first and only commercial producer of neuromorphic artificial intelligence chips….

To say the last quarter of 2021 was eventful would be an understatement. Quality continues to pay off for patient investors, as does traditional ‘value’ seeking behaviour. In this article, we provide a short update on some of the ASX’s most popular stocks. ANZ – Fourth largest bank, institutional banking focus 1.4% 30.8% ANZ underperformed…

Leading independent, full-service financial services firm, Canaccord Genuity, has released its “Top Australian Stock Picks for 2022”. The publication is a collection of Canaccord’s top 26 stock picks across a diverse group of sectors including Metals and Mining, EV Materials, Energy, Mining Services, Sustainability, Software and Services, Internet, Telecommunications, Retail, Beverages, Health Care and Wealth…

Subscribers to the IPO of salary-advance fintech Beforepay (ASX: B4P) were left in shock following the company’s 40% tumble within the first hours of trade. Shares fell from the listing price of $3.41 to $2.20 by mid-afternoon, crushing any hopes of instant stock market success to become the next generation lender. BeforePay is a pay-on-demand…

Megaport Ltd (ASX: MP1) shares have fallen 12% in morning trade after providing a second-quarter business update. Today’s selling in the cloud infrastructure provider has been amplified by a broader tech sell-off on the NASDAQ 100 overnight, which fell 2.57%. Annualised revenue now $110 million Key financial highlights from the second quarter (Q2) ending December 31 include: Monthly recurring revenue…

Australia’s longest-standing “responsible investment” manager, Australian Ethical, has launched a new High Conviction fund to complement its suite of existing actively-managed funds. Support for the Australian shares and emerging companies strategies has grown sixfold in just five years as Australians have become more ethically minded than ever before. From being just a point of conversation,…

Florida-based active global equities manager GQG Partners Inc. (ASX: GQG) is set to start trading on Tuesday after the business completed the biggest initial public offering (IPO) of 2021. The business raised just shy of $1.2 billion, valuing GQG at $5.9 billion. Let’s dive into the business and why it could be an interesting investment. The newest fundie in…